Search results
May 3, 2004 · Eric Tomlinson. ERIC TOMLINSON is Chief Executive Officer of Altea Therapeutics. He has extensive expertise in pharmaceutical and biotechnology drug and gene delivery research and development. He ...
Aug 21, 2015. Targacept Inc.’s 15-year run as an independent company ended Thursday much as it began — tying its future to the hope of a biopharmaceutical drug breakthrough. Please subscribe ...
Nov 21, 2002 · Tomlinson established and led the worldwide Advanced Drug Delivery Research Program for Ciba-Geigy Pharmaceuticals, and as CEO of GeneMedicin, he was responsible for its venture financings ...
Specialties: Database management and development, Microsoft software training, Quality systems auditing and analysis. | Learn more about Eric Tomlinson's work experience, education, connections ...
- 47
- 46
- Amylin Pharmaceuticals
- Dayton, Ohio, United States
May 3, 2004 · ERIC TOMLINSON is Chief Executive Officer of Altea Therapeutics. He has extensive expertise in pharmaceutical and biotechnology drug and gene delivery research and development.
When Eric Tomlinson, PhD, went scouting for a new business development director for Atlanta-based Altea Therapeutics, the biotech pro knew that any candidate for the job would need at least one extremely clear attribute: a host of contacts in the business. He wasn’t disappointed. His pick — Steven Damon — has “a Rolodex sine qua non.”
Jul 2, 2008 · Altea Therapeutics and Hospira enter into Development and Commercialization Agreement for Transdermal ... and small drugs," said Dr. Eric Tomlinson, PhD, DSc, President and CEO of Altea ...
